Why the study?
Does a saponin-inactivated Mycoplasma bovis vaccine prevent pneumonia and reduce lung lesions in 3-4 week-old calves exposed to a virulent challenge?
Does a saponin-inactivated Mycoplasma bovis vaccine prevent pneumonia and reduce lung lesions in 3-4 week-old calves exposed to a virulent challenge?
A single dose of saponin-inactivated Mycoplasma bovis vaccine provides significant protection against virulent challenge in calves, reducing clinical signs and lung lesions.
Provides proof-of-concept for M. bovis vaccine in calves; leaves open translation to field practice pending trials.
No takes yet. Share an insight, caveat, or question.
Benjamin McGrath (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: